Injective's MultiVM Era Begins: Over 30 Projects Launch on Native EVM Today
@Injective $INJ #Injective
Injective just hit a major milestone—its native Ethereum Virtual Machine is now live on mainnet, kicking off the MultiVM era with over 30 projects launching right out of the gate. Think of Injective as this powerful financial engine that gives developers the freedom to mix and match execution environments. The result? Customized DeFi apps that work seamlessly across different blockchains. This launch is the product of years of work, setting Injective up as a serious hub for advanced on-chain finance.
Since 2018, Injective’s team has fine-tuned its Layer 1 to handle financial use cases, delivering super-fast transactions that settle in less than a second, all while keeping fees low. It connects easily with Ethereum, Solana, and Cosmos, so moving assets across chains feels effortless, boosting both liquidity and utility. The modular design clears the way for builders to experiment and launch new protocols quickly. INJ keeps things running smoothly—it covers transaction fees, powers staking that strengthens network security, and hands out rewards to active participants. Holders have a real say in Injective’s direction through governance votes. And with regular community buybacks burning millions of tokens each month, the ecosystem stays lean and incentives stay strong.
With the native EVM now live, Injective finally brings its MultiVM vision to life, combining CosmWasm and EVM for dual execution. Developers get the best of both worlds: Ethereum’s deep tooling and Cosmos’s raw efficiency. That opens the door for hybrid apps that really perform. In the world of derivatives, this means protocols can pull off complex calculations for options and perpetuals, all while tapping into shared liquidity for better pricing. Just look at Helix, Injective’s own DEX—it’s already using these tools for spot and leveraged trading across a range of assets. The liquidity layer brings together volume from different ecosystems, building stronger, more attractive markets—especially for big traders.
Chainlink came on board as Injective’s go-to oracle in early November, delivering real-time data for crypto, stocks, gold, forex, and ETFs. This upgrade makes settlements more secure and reliable, which is crucial for bringing traditional assets into DeFi. Injective keeps pushing into real-world assets, letting users trade things like Nvidia stock, gold, and major currency pairs right in DeFi, all composable and on-chain. Institutional players are paying attention too: Pineapple Financial, listed on the NYSE, announced a $100 million INJ treasury move in September, with staking supported by an institutional validator since October. And with a new US exchange-traded fund on the horizon, even more investors will be able to join through channels they already know.
New tools are speeding up Injective’s growth. The iBuild platform, which rolled out in mid-November, uses AI so anyone can build and launch DeFi apps in minutes—no coding required. Injective Trader, launched a bit later, gives pros a way to test and automate trading strategies. Now, with the MultiVM campaign launching alongside Bantr, more builders are getting involved, drawn by fresh incentives. For folks in the Binance ecosystem, this means deeper markets and access to innovative products right now, from yield farming to next-level hedging.
As on-chain derivatives and real-world asset integration get stronger, Injective’s infrastructure is ready for the mainstream, giving users and holders more value than ever.
Which Injective feature launching in 2025—like the native EVM or iBuild—do you think will shake up DeFi the most? Drop your thoughts below.
Injective just hit a major milestone—its native Ethereum Virtual Machine is now live on mainnet, kicking off the MultiVM era with over 30 projects launching right out of the gate. Think of Injective as this powerful financial engine that gives developers the freedom to mix and match execution environments. The result? Customized DeFi apps that work seamlessly across different blockchains. This launch is the product of years of work, setting Injective up as a serious hub for advanced on-chain finance.
Since 2018, Injective’s team has fine-tuned its Layer 1 to handle financial use cases, delivering super-fast transactions that settle in less than a second, all while keeping fees low. It connects easily with Ethereum, Solana, and Cosmos, so moving assets across chains feels effortless, boosting both liquidity and utility. The modular design clears the way for builders to experiment and launch new protocols quickly. INJ keeps things running smoothly—it covers transaction fees, powers staking that strengthens network security, and hands out rewards to active participants. Holders have a real say in Injective’s direction through governance votes. And with regular community buybacks burning millions of tokens each month, the ecosystem stays lean and incentives stay strong.
With the native EVM now live, Injective finally brings its MultiVM vision to life, combining CosmWasm and EVM for dual execution. Developers get the best of both worlds: Ethereum’s deep tooling and Cosmos’s raw efficiency. That opens the door for hybrid apps that really perform. In the world of derivatives, this means protocols can pull off complex calculations for options and perpetuals, all while tapping into shared liquidity for better pricing. Just look at Helix, Injective’s own DEX—it’s already using these tools for spot and leveraged trading across a range of assets. The liquidity layer brings together volume from different ecosystems, building stronger, more attractive markets—especially for big traders.
Chainlink came on board as Injective’s go-to oracle in early November, delivering real-time data for crypto, stocks, gold, forex, and ETFs. This upgrade makes settlements more secure and reliable, which is crucial for bringing traditional assets into DeFi. Injective keeps pushing into real-world assets, letting users trade things like Nvidia stock, gold, and major currency pairs right in DeFi, all composable and on-chain. Institutional players are paying attention too: Pineapple Financial, listed on the NYSE, announced a $100 million INJ treasury move in September, with staking supported by an institutional validator since October. And with a new US exchange-traded fund on the horizon, even more investors will be able to join through channels they already know.
New tools are speeding up Injective’s growth. The iBuild platform, which rolled out in mid-November, uses AI so anyone can build and launch DeFi apps in minutes—no coding required. Injective Trader, launched a bit later, gives pros a way to test and automate trading strategies. Now, with the MultiVM campaign launching alongside Bantr, more builders are getting involved, drawn by fresh incentives. For folks in the Binance ecosystem, this means deeper markets and access to innovative products right now, from yield farming to next-level hedging.
As on-chain derivatives and real-world asset integration get stronger, Injective’s infrastructure is ready for the mainstream, giving users and holders more value than ever.
Which Injective feature launching in 2025—like the native EVM or iBuild—do you think will shake up DeFi the most? Drop your thoughts below.
Disclaimer: Includes third-party opinions. No financial advice. May include sponsored content. See T&Cs.
INJ
5.73
+1.23%